<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; ACTA</title>
	<atom:link href="http://www.tapanray.in/tag/acta/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Counterfeit Drugs and ACTA: Should the global menace related to &#8216;Public Health and Safety&#8217; be mixed-up with Intellectual Property Rights?</title>
		<link>http://www.tapanray.in/counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights</link>
		<comments>http://www.tapanray.in/counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights/#comments</comments>
		<pubDate>Mon, 02 Jul 2012 00:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ACTA]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Intellectual]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[mixed-up]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Property]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[related]]></category>
		<category><![CDATA[Rights]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=72</guid>
		<description><![CDATA[Here in this article, I am talking about drugs or medicines, which you may ultimately land up into buying, quite innocently though, against your doctor’s prescriptions, without having an inkling that these drugs can push you into serious health hazards, &#8230; <a href="http://www.tapanray.in/counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The issue of ‘Counterfeit Drugs’ in India: An “Ostrich Syndrome’</title>
		<link>http://www.tapanray.in/the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome</link>
		<comments>http://www.tapanray.in/the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome/#comments</comments>
		<pubDate>Mon, 14 Feb 2011 00:30:00 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ACTA]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Dubai]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[hazard]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Ostrich]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[potential]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[related]]></category>
		<category><![CDATA[Syndrome]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[trademark]]></category>
		<category><![CDATA[USFDA]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=302</guid>
		<description><![CDATA[Ellen‘t Hoen, former Policy Advocacy Director of MSF’s Campaign for Access to Essential Medicines wrote in April 2009 as follows: “People often seem to confuse counterfeit, substandard and generic medicines – using the terms interchangeably. But they are very separate &#8230; <a href="http://www.tapanray.in/the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Concerted action by all stakeholders on counterfeit medicines is the need of the hour.</title>
		<link>http://www.tapanray.in/concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour</link>
		<comments>http://www.tapanray.in/concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 00:30:06 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ACTA]]></category>
		<category><![CDATA[action]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Concerted]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[hour]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[stakeholders]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=768</guid>
		<description><![CDATA[The concern of some section of the stakeholders that IPR is being extended to the definition of counterfeit medicines, in my view, is misplaced. As even in India, &#8216;misbranding&#8217; though an integral part of IPR, is considered as a public &#8230; <a href="http://www.tapanray.in/concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
